. Author manuscript; available in PMC: 2011 Dec 1.

Published in final edited form as: Am J Cardiol. 2010 Sep 21;106(11):1606–1608. doi: 10.1016/j.amjcard.2010.07.039

Table 1.

Baseline Characteristics

Variable	Controls (n=38)	Metabolic Syndrome(n=36)
Age (year)	49 ± 12	53 ± 11
Waist circumference (inches)	36 ± 6	43 ± 5^*
Male: Female	7:31	10:26
Blood Pressure
Systolic (mmHg)	118 ± 13	132 ± 12^*
Diastolic (mmHg)	73 ± 8	82 ± 10^*
Fasting Glucose (mg/dl)	89 ± 7	101 ± 11^*
Total Cholesterol (mg/dl)	188 ± 32	200 ± 27
HDL-Cholesterol (mg/dl)	54 ± 14	40 ± 11^*
LDL-Cholesterol (mg/dl)	119 ± 26	130 ± 20
Triglycerides (mg/dl)¹	72	140 ^*
Insulin (mIU/mL)	3.5 ± 0.7	7.5 ± 1.2^*
HOMA-IR	1.8 (0.91,2.9)	4.1 (2.5,6.3)^*
hsCRP (mg/L)¹	1.4	3.5^*
Progenitor Cells (CD34+, mfi)	12.1 (9.9, 21.4)	8.4 (6.5, 11.7)^*
EPC (CD34+/KDR+, mfi)	5.1 (3.3,8.9)	3.6 (2.5,6.7)^*

Unless otherwise noted, data were mean ± SD;

Data were medians;

p<0.05,

^**

p<0.01,

^***

p<0.001, compared to Controls

Abbreviations: EPC: endothelial progenitor cells; HDL-High density lipoprotien; HOMA_IR: Homeostasis Model Assessment of Insulin Resistance; hsCRP: High sensitivity C-reactive protein; LDL-Low density lipoprotein